News

The U.S. alcoholic beverages sector has entered a severe post-pandemic downturn, marked by a 19.8% drop in wine volumes from 2021 highs—translating to over 100 million fewer cases sold annually—and spirits giants saddled with a collective $22 billion in maturing inventory, the largest overhang in more than a decade. This crisis originated from aggressive production expansions between 2021 and 2022, when at-home alcohol sales jumped 15-20% year-over-year during lockdowns, leading to excess capacity that now collides with contracting demand down 5-10% due to inflation and shifting health priorities.

Wine Segment's Sharp Decline Hits Volumes and Vineyards

U.S. wine depletions shrank 3.1% in 2025 to 298 million cases overall, with table wines falling 5% while sparkling varieties eked out just 1% growth—rates well below pre-pandemic norms. Off-premise sales, which account for 75% of total volume, plummeted 19.8% from their Q4 2021 peak, striking Cabernet Sauvignon with a 12% year-over-year drop and Chardonnay down 8% as shoppers shifted toward ready-to-drink (RTD) cocktails that gained 12% market share. Even premium wines priced above $15 per bottle suffered 7% value erosion through heavy discounting, leaving the category's total revenue stuck at $72 billion despite 2% inflation-adjusted price hikes.

This sales slump has rippled through the supply chain, forcing California vineyards to crush just 6.8 million tons of grapes in 2025—a 10% year-over-year decline—with Zinfandel acreage cut by 15% and yields hitting a historic low of 3.5 tons per acre. Imports have partially offset the shortfall, rising 8% to 450 million cases and led by Prosecco's 22% surge and Sauvignon Blanc up 14%.

Spirits Giants Face Crushing $22B Inventory Burden

The five largest spirits producer: 

• Diageo
• Pernod Ricard
• Campari
• Brown-Forman
• Rémy Cointreau

These giants now hold $22 billion worth of aging inventory, exceeding levels seen after the 2008 financial crisis. For context, Rémy Cointreau's cognac stockpile alone totals €1.88 billion—nearly double its €1.2 billion annual revenue and 90% of its market capitalization. U.S. spirits depletions followed suit, declining 2.5% year-over-year to 255 million cases, with tequila volumes off 4%, whiskey down 3%, and vodka slipping 2%.

Much of this excess traces back to pandemic-era output surges for spirits that require extended aging: Scotch and American whiskeys (3-7 years), cognac (2-12 years), and tequila (1-3 years). In Mexico, tequila inventories exceed 500 million liters—equivalent to 50% of annual production—while U.S. sales of brands like Don Julio and Jameson have fallen 5-7% and accelerated quarter-over-quarter. Rising debt levels compound the pain, with Diageo and Pernod Ricard's net debt-to-EBITDA ratios climbing above 4x, far from the historical 2-3x norm.

Shifting Demand: Health Trends, GLP-1 Drugs, and Generational Changes

A structural decline in consumption underpins these figures, as per-capita U.S. alcohol intake has fallen 7% from its 2000s peak, with 40% of Gen Z adults (ages 18-27) now abstaining compared to just 20% of Boomers. GLP-1 weight-loss drugs like Wegovy and Ozempic, used by over 12 million Americans by 2026, further suppress impulse and high-calorie alcohol purchases, correlating with a 3-5% volume drop. "Dry" occasions have risen 25%, including 25% participation in Dry January, boosting non-alcoholic beer, wine, and spirits by 25-30% year-over-year to claim 2% of the total alcohol market.

Economic pressures exacerbate the shift, with real disposable income down 2.5% year-over-year driving a 15% increase in trading down to mid-tier options ($10-15 range). On-premise channels remain at only 85% of pre-COVID levels, while RTDs have captured 8% market share—a 400% rise since 2020.

Supply Chain Disruptions and Mounting Financial Pressures

Distillery closures highlight the strain: Suntory shuttered its Jim Beam plant in Kentucky for a full year, and over 50 craft distilleries—10% of the U.S.'s 1,000-plus total—have filed for bankruptcy. Alcohol industry stocks have lagged the S&P 500 by 23 percentage points year-to-date, with Diageo and Pernod Ricard shares down 20-25%. Looking ahead, today's production cuts could create shortages in 5-10 years if demand rebounds at a 3-5% compound annual growth rate after 2027.

2026 Outlook: Contraction Before Potential Stabilization

Analysts at Astute Aanlytica project U.S. alcohol volumes to contract another 2% in 2026 to 950 million cases, with revenues holding flat at $280 billion through selective pricing adjustments. Bright spots include RTDs growing 15%, non-alcoholic options up 25%, and premium tequila recovering 5%. 

In contrast, wine faces a further 4% decline, and aged whiskeys another 3%. The sector is pivoting via over $10 billion in mergers and acquisitions, such as Gallo's $775 million purchase of Four Roses, but full recovery demands 18-24 months of destocking, deeper non-alcoholic integration, and strategies to counter GLP-1 impacts—or risk price wars that erode 10-15% of profit margins